ImmuneOnco Biopharmaceuticals (Shanghai) IncHKEX: 1541

Proxy Form for the Extraordinary General Meeting to be held on Wednesday, December 9, 2026

· Issued by ImmuneOnco Biopharmaceuticals (Shanghai) Inc via HKEXnews

Filed with HKEX · Stock code 1541 · · 1 page · English

Summary by 6ix AI

This filing is a proxy form for an extraordinary general meeting of ImmuneOnco Biopharmaceuticals (Shanghai) Inc. The meeting is scheduled to consider several resolutions, including the appointment of a new independent director and changes to the company's auditor. Shareholders are invited to appoint a proxy to vote on their behalf at the meeting.

Written by 6ix AI from the company’s filing. How 6ix writes summaries

ImmuneOnco Biopharmaceuticals (Shanghai) Inc on 6ix

Earlier from ImmuneOnco Biopharmaceuticals (Shanghai)

All ImmuneOnco Biopharmaceuticals (Shanghai) news releases